BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 103 filers reported holding BIOXCEL THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $344,426 | -15.6% | 18,458 | -2.8% | 0.00% | -25.0% |
| Q4 2022 | $407,991 | +126.7% | 18,994 | +24.6% | 0.00% | +100.0% |
| Q3 2022 | $180,000 | -17.8% | 15,246 | -8.1% | 0.00% | 0.0% |
| Q2 2022 | $219,000 | -63.6% | 16,596 | -42.3% | 0.00% | -71.4% |
| Q1 2022 | $601,000 | -8.7% | 28,754 | -11.2% | 0.01% | 0.0% |
| Q4 2021 | $658,000 | -36.7% | 32,375 | -5.6% | 0.01% | -30.0% |
| Q3 2021 | $1,040,000 | +10.3% | 34,278 | +5.7% | 0.01% | +25.0% |
| Q2 2021 | $943,000 | -50.4% | 32,438 | -26.4% | 0.01% | -57.9% |
| Q1 2021 | $1,902,000 | -5.9% | 44,080 | +0.7% | 0.02% | -17.4% |
| Q4 2020 | $2,022,000 | +63.6% | 43,760 | +53.5% | 0.02% | +27.8% |
| Q3 2020 | $1,236,000 | -15.4% | 28,509 | +3.4% | 0.02% | -10.0% |
| Q2 2020 | $1,461,000 | – | 27,570 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 60,000 | $151,800 | 0.16% |
| XTX Topco Ltd | 33,605 | $85,021 | 0.02% |
| Beacon Pointe Advisors, LLC | 301,735 | $763,390 | 0.01% |
| AllSquare Wealth Management LLC | 4,527 | $11,453 | 0.01% |
| Virtus ETF Advisers LLC | 4,646 | $11,754 | 0.01% |
| Y-Intercept (Hong Kong) Ltd | 27,553 | $69,709 | 0.01% |
| SeaCrest Wealth Management, LLC | 16,550 | $41,872 | 0.01% |
| Hennion & Walsh Asset Management, Inc. | 33,940 | $85,868 | 0.01% |
| Cutler Group LLC / CA | 4,000 | $50 | 0.01% |
| Capital Investment Advisory Services, LLC | 17,991 | $45,517 | 0.00% |